November 10, 2022

Consolidated Financial Results

for the Second Quarter Ended September 30, 2022

Terumo CorporationIFRS

Company name:

TERUMO CORPORATION

Listing:

Tokyo Stock Exchange

Securities code:

4543

URL:

https://www.terumo.com/

Representative:

Shinjiro Sato, President and CEO

Inquiries:

Kenichi Hata, General Manager, Investor Relations Dept.

Telephone:

+81-3-6742-8550

Scheduled date to file quarterly securities report:

November 14, 2022

Scheduled date to commence dividend payments:

December 5, 2022

Preparation of supplementary material on quarterly financial results: Yes

Holding of quarterly financial results briefing:

Yes (for Securities analysts, Institutional

investors)

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the six months ended September 30, 2022 (from April 1, 2022 to September 30, 2022)

(1) Consolidated operating results (cumulative)

(Percentages indicate year-on-year changes.)

Revenue

Operating profit

Profit before tax

Profit for the

Profit attributable

Total

comprehensive

period

to owners of the

parent

income

Six months ended

Millions of

%

Millions of

%

Millions of

%

Millions of

%

Millions of

%

Millions of

%

yen

yen

yen

yen

yen

yen

September 30,

403,316

17.0

55,977

(15.0)

54,624

(16.3)

40,321

(19.3)

40,321

(19.3)

186,667

221.0

2022

September 30,

344,637

21.7

65,857

57.5

65,282

60.6

49,988

57.4

49,988

57.0

58,146

209.0

2021

Basic earnings

Diluted earnings

per share

per share

Six months ended

Yen

Yen

September 30,

53.37

53.35

2022

September 30,

66.11

66.07

2021

yen

September 2021: 74,137 million yen

(Note) Adjusted

operating profit September

2022: 70,429 million

(2) Consolidated financial position

Equity attributable to

Ratio of equity

Total assets

Total equity

attributable to owners of

owners of the parent

the parent to total assets

As of

Millions of yen

Millions of yen

Millions of yen

%

September 30, 2022

1,658,931

1,171,105

1,171,105

70.6

March 31, 2022

1,473,693

1,012,313

1,012,313

68.7

2. Cash dividends

Annual dividends per share

First quarter-end

Second quarter-end

Third quarter-end

Fiscal year-end

Total

Yen

Yen

Yen

Yen

Yen

Fiscal year ended

16.00

18.00

34.00

March 31, 2022

Fiscal year ending

19.00

March 31, 2023

Fiscal year ending

March 31, 2023

19.00

38.00

(Forecast)

(Note)Revision from the dividend forecast, which is published in the most recent: Yes

The company revises second quarter-end and year-end dividends per share for the fiscal year ending March 2023 from 18yen to 19yen.

Please refer to the November 10, 2022 press release, "Terumo Revises Interim Dividend Distribution and Year-End Dividends Forecast for Fiscal Year Ending March 31, 2023."

3. Consolidated Forecast for the Fiscal Year Ending March, 2023 (From April 1, 2022 to March 31, 2023) (Percentages indicate year-on-yearchanges.)

Adjusted operating

Profit for the year

Revenue

Operating profit

attributable to owners

Earnings per share

profit

of the parent

Fiscal year ending

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

March, 2023

775,000

10.2

151,000

12.3

132,000

13.8

100,000

12.6

133.88

(Note)Revision of forecast for the fiscal year ending March, 2023: None

The Company resolved to repurchase its own shares at the board of directors meeting held on May 12, 2022. Basic earnings per share is calculated by taking into consideration effects of the situation of acquisition of them.

• Assumed exchange rate for fiscal year ending March, 2023: USD1=JPY130, EUR1=JPY137

*Notes

(1) Changes in significant subsidiaries during the current quarterly consolidated cumulative period (changes in specified subsidiaries resulting in changes in the scope of consolidation): None

New Company (Company Name) , Excluded Company (Company Name)

  1. Changes in accounting policies and changes in accounting estimates
  1. Changes in accounting policies required by IFRS: None
  2. Changes in accounting policies other than (i): None
  3. Changes in accounting estimates: None
  1. Number of shares outstanding (common stock)

(i) Number of outstanding shares at the end of

As of September 30,

759,521,040 shares As of March 31, 2022

759,521,040 shares

the period (including treasury shares)

2022

(ii) Treasury shares at the end of the period

As of September 30,

6,354,109 shares As of March 31, 2022

3,194,976 shares

2022

(iii) Average number of shares during the

Six months ended

755,432,665 shares Six months ended

756,100,350 shares

period (cumulative quarterly)

September 30, 2022

September 30, 2021

  • Quarterly financial statements are not subject to quarterly reviews by certified accountants or audit firms.
  • Explanation on appropriate use of financial results forecasts and other special notes
    1. Forward-lookingstatements, including earnings forecasts, contained in these disclosure materials are based on currently available information and assumptions believed to be reasonable by management. This is not a promise or guarantee by Terumo that it will achieve these goals. In addition, actual results may differ significantly due to several factors. For the assumptions that are the premise of the earnings forecast and the precautions for using the earnings forecast, refer to [Attachment], page 5, "1. Overview of Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 (3) Forecasts, including the Consolidated Financial Results for the Fiscal Year Ending March 31, 2023".
    2. Adjusted operating profit factors out amortization expense for intangible assets obtained during acquisitions and one-off income and expenses from operating profit. In addition, adjusted operating profit is consistent with segment profit. We are disclosing adjusted operating profit as we are using it as a performance indicator.

[Terumo Corporation] Financial Results for the First Half of the Fiscal Year Ending March 31, 2023

Table of contents of attached materials

1. Overview of Financial Results for the First Half of the Fiscal Year Ending March 31, 2023 ...............................

2

(1)

Overview of Consolidated Business Results.....................................................................................................

2

(2)

Overview of Consolidated Statement of Financial Position..............................................................................

5

(3)

Forecasts, including the Consolidated Financial Results for the Fiscal Year Ending March 31, 2023 .............

5

2. Condensed Consolidated Financial Statements .....................................................................................................

6

(1)

Condensed Consolidated Statement of Financial Position ................................................................................

6

(2)

Condensed Consolidated Statement of Profit or Loss and Condensed Consolidated Statement of

Comprehensive Income ..................................................................................................................................

8

(3)

Condensed Consolidated Statement of Changes in Equity..............................................................................

10

(4)

Notes Pertaining to Condensed Consolidated Financial Statements ................................................................

11

(i) Going Concern Assumption...........................................................................................................................

11

(ii) Segment Information ....................................................................................................................................

11

(iii) Assets Held for Sale....................................................................................................................................

14

(ⅳ) Impairment of Non-Financial Assets...........................................................................................................

14

(v) Subsequent Events .......................................................................................................................................

15

1

[Terumo Corporation] Financial Results for the First Half of the Fiscal Year Ending March 31, 2023

1. Overview of Financial Results for the First Half of the Fiscal Year Ending March 31, 2023

(1) Overview of Consolidated Business Results

In the first half of the current fiscal year (from April 1 to September 30, 2022), the Group's sales trended strongly in general amid the recovery in medical demand which had declined in the previous fiscal year due to the COVID-19 pandemic, as well as the positive impact by yen depreciation. Operating profit declined year on year due to the inflation on manufacturing cost.

Financial results for the first half are as follows:

(Unit: Millions of yen)

For the six

For the six

Growth

months ended

months ended

Growth (%)

excluding impact

September

September

of FX

30, 2021

30, 2022

translations (%)

Revenue

344,637

403,316

17.0

5.1

Gross profit

186,244

206,992

11.1

2.0

Adjusted operating profit

74,137

70,429

(5.0)

(9.6)

Operating profit

65,857

55,977

(15.0)

(16.3)

Profit before tax

65,282

54,624

(16.3)

Profit for the period

49,988

40,321

(19.3)

Profit for the period

attributable to owners of the

49,988

40,321

(19.3)

parent

Revenue by geographic areas for the first half is as follows:

(Unit: Millions of yen)

For the six

For the six

Growth

Geographic areas

months ended

months ended

Growth (%)

excluding impact

September

September

of FX

30, 2021

30, 2022

translations (%)

Japan

102,412

101,235

(1.1)

(1.1)

Europe

68,307

77,181

13.0

5.2

Americas

106,343

138,096

29.9

7.1

China

30,124

38,371

27.4

8.0

Asia and others

37,449

48,430

29.3

14.3

Overseas total

242,225

302,080

24.7

7.8

Total

344,637

403,316

17.0

5.1

2

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Terumo Corporation published this content on 10 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2022 06:46:03 UTC.